Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma.

Hepatocellular carcinoma (HCC) is a leading cause of death in patients with cirrhosis and has a rising mortality rate in the United States. ¹ Racial and ethnic minorities experience a disproportionate burden of HCC, including higher incidence rates, more late-stage diagnoses, and worse survival. ^{2 , 3} These disparities are complex in nature and can be attributed to many proximal, intermediate, and distal determinants, such as health literacy and behaviors, social support, social needs, social determinants of health, and access to health care. ⁴ Prior studies have identified racial and ethnic differences in clinical factors, including receipt of HCC surveillance and tumor stage ⁵ ; however, few studies have examined differences in patient-reported barriers that may partly explain observed disparities. Understanding these data is essential to inform interventions to address and mitigate disparities. Therefore, we described patient-reported barriers to medical care and examined differences in barriers by race and ethnicity in a large, diverse population of patients newly diagnosed with HCC.
(Copyright © 2023 AGA Institute. Published by Elsevier Inc. All rights reserved.)